BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    CAPTURE-R READY-SCREEN (I AND II)

    MDR report key: 16496213 · Received March 7, 2023

    Report

    Report Number
    1034569-2023-00006
    Event Type
    Malfunction
    Date Received
    March 7, 2023
    Date of Event
    February 7, 2023
    Report Date
    March 6, 2023
    Manufacturer
    IMMUCOR, INC.
    Product Code
    QHT
    UDI-DI
    10888234000648
    PMA / PMN Number
    102707/0.0
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    NY, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    ON (B)(6) 2023 IMMUCOR PERFORMED S ANTIGEN CONFIRMATION ON CELLS 1 AND 2 OF RETURNED CRRS2 LOT X548 USING ANTI-S ANTISERUM LOT 057035 WITH RETENTION CRRIRC LOT 221221. CONTROLS PERFORMED AS EXPECTED, AND CELLS 1 AND 2 RESULTED POSITIVE FOR THE S ANTIGEN AS EXPECTED. RETURN PRODUCT PERFORMED AS EXPECTED. ON (B)(6) 2023 IMMUCOR USED REMOTE ACCESS TO REVIEW THE RESULTS FROM (B)(6) 2023. NO ERRORS NOTED ON PLATE ID X54807390 TESTED AT 2145 ON (B)(6) 2023; CELL 1 - S-,S+, CELL 2 - S+,S+ (BOTH CELLS WERE NEGATIVE). IT WAS NOTED THAT THE WELL FILL CHECK WAS VERY ICTERIC FOR THE PRETRANSFUSION SAMPLE (I.E. THE SAMPLE APPEARED TO BE VERY ICTERIC). ON (B)(6) 2023 IMMUCOR PERFORMED JKB ANTIGEN CONFIRMATION ON CELL 1 OF RETURNED CRRS2 LOT X548 USING ANTI-JKB ANTISERUM LOT TN0038 JKB WITH RETENTION CRRIRC LOT 221221. CONTROLS PERFORMED AS EXPECTED, AND CELL 1 RESULTED POSITIVE FOR THE JKB ANTIGEN AS EXPECTED. RETURN PRODUCT PERFORMED AS EXPECTED. ON (B)(6) 2023 IMMUCOR PERFORMED A 2_CELL ASSAY ON THE NEO IRIS USING RETURNED SAMPLES PRE-TRANS 1, PRE-TRANS 2, AND POST TRANS WITH RETENTION CRRS2 LOT X548 AND RETENTION CRRIRC LOT 221221. CONTROLS PERFORMED AS EXPECTED, AND ALL THREE SAMPLES RESULTED NEGATIVE. ON (B)(6) 2023 IMMUCOR PERFORMED A 3_CELL ASSAY ON THE NEO IRIS USING THE THREE RETURNED SAMPLES WITH RETENTION CRRS3 LOT R445 AND RETENTION CRRIRC LOT 221221. CONTROLS PERFORMED AS EXPECTED, AND ALL THREE SAMPLES RESULTED NEGATIVE. ON (B)(6) 2023 IMMUCOR PERFORMED A SCREEN ASSAY ON THE ECHO LUMENA USING THE THREE RETURNED SAMPLES WITH CRRS3 LOT R445 AND RETENTION CRRIRC LOT 221221. CONTROLS PERFORMED AS EXPECTED, AND ALL THREE SAMPLE RESULTED POSITIVE. PRE-TRANS 1 RESULTED 1+, ?, ? FOR CELLS 1, 2, AND 3. CELL 2 WAS VISUALLY INTERPRETED AS NEGATIVE. CELL 3 WAS VISUALLY INTERPRETED AS POSITIVE. THE CELL BUTTON FOR CELL 3 IS SMALLER THAN THE BUTTONS FOR THE NEGATIVE REACTIONS ON THE PLATE. PRE-TRANS 2 RESULTED 1+, 1+, 1+ FOR CELLS 1, 2, AND 3. POST-TRANS RESULTED 1+, ?, ? FOR CELLS 1, 2, AND 3. CELL 2 WAS VISUALLY INTERPRETED AS NEGATIVE. CELL 3 WAS VISUALLY INTERPRETED AS POSITIVE. THE CELL BUTTON FOR CELL 3 IS SMALLER THAN THE BUTTONS FOR THE NEGATIVE REACTIONS ON THE PLATE. ON (B)(6) 2023 IMMUCOR PERFORMED A SELECTED CELL ANTIBODY DETECTION ASSAY BY MANUAL TUBE METHOD. THE SELECTED CELL PANEL CONSISTED OF 3 JK(A-B+), S+S- RED CELLS AND 3 JK(A+B-), S-S+ RED CELLS AND TESTED WITH ALL THREE RETURNED SAMPLES USING PEG AS ENHANCEMENT MEDIA. ALL THREE SAMPLES RESULTED NEGATIVE WITH ALL 6 SELECTED RED CELLS. AN ANTIBODY TITER WAS NOT INDICATED. ON (B)(6) 2023 IMMUCOR PERFORMED A READY ID ASSAY ON THE ECHO LUMENA USING RETURNED SAMPLE PRE-TRANS 2 (THE ONLY SAMPLE WITH ENOUGH VOLUME TO COMPLETE THE ASSAY) WITH RETENTION CRRID LOT ID445 AND RETENTION CRRRIC LOT 221221. PLATE CONTROLS PERFORMED AS EXPECTED, AND THE RETURNED SAMPLE RESULTED WITH 1+ REACTIVITY ON CELLS 3 AND 12, AND WITH EQUIVOCAL REACTIONS ON CELLS 1, 5, 9, 11, AND 13. THIS PANEL WAS CHOSEN TO DIFFERENTIATE IF THE ANTIBODY PRESENT IS OF THE S OR JKB SPECIFICITY. ALL CELLS THAT WOULD HAVE INCLUDED ONE AND EXCLUDED THE OTHER RESULTED NEGATIVE. NO IDENTIFIABLE IDENTIFICATION COULD BE MADE. ALL EQUIVOCAL REACTIONS WERE VISUALLY INTERPRETED AS NEGATIVE. ON (B)(6) 2023 AN IMMUCOR SERVICE TECHNICIAN WENT TO CUSTOMER SITE TO PERFORM AN UNEXPECTED REACTION CHECKLIST TO MAKE SURE THAT NEO IRIS INSTRUMENT SERIAL NUMBER (B)(4) WAS FULLY OPERATIONAL AND EVERYTHING WAS WITHIN THE SPECIFICATIONS. PROACTIVE MAINTENANCE WAS PERFORMED BUT NO INSTRUMENT ISSUES WERE NOTED. THE CUSTOMER ISSUE WAS REPRODUCED WITH RETURNED SAMPLES ONLY. RETENTION PRODUCT PERFORMED AS EXPECTED. NO DEFECT OR DEFICIENCY WAS IDENTIFIED FOR EITHER THE INSTRUMENT OR THE ASSAY REAGENTS. THIS IS A SAMPLE RELATED ISSUE. THE INTERNAL IMMUCOR REFERENCE FOR THIS EVENT IS PR#(B)(4).

    Description of Event or Problem · 0

    ON (B)(6) 2023 A CUSTOMER REPORTED UNEXPECTED NEGATIVE REACTIVITY (MISSED ANTI-S) WITH CAPTURE-R READY-SCREEN (I AND II) ON THEIR NEO IRIS INSTRUMENT.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    62895 CAPTURE-R READY-SCREEN (I AND II) REAGENT RED BLOOD CELLS QHT IMMUCOR, INC. X548 10888234000648

    Patients

    Seq Age Sex Outcome Treatment
    1 21 YR Male